Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Pinsky

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Annals of the New York Academy of Sciences|January 1, 1976
Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanomaC M Pinsky, Y Hirshaut, H J Wanebo, et al.
Cancer|October 1, 1976
Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's diseaseD C Case, J A Hansen, E Corrales, et al.
Blood|May 1, 1977
Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissionsD C Case, J A Hansen, E Corrales, et al.
Cancer Treatment Reports|November 1, 1978
Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary reportH J Wanebo, E Y Hilal, C M Pinsky, et al.
The New England Journal of Medicine|August 31, 1978
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancerH J Wanebo, B Rao, C M Pinsky, et al.
Annals of Surgery|December 6, 1997
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancerK Hughes, C M Pinsky, N J Petrelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study GroupF L Moffat, C M Pinsky, L Hammershaimb, et al.
Cancer|May 15, 1981
DNCB reactivity and prognosis in 419 patients with malignant melanomaE S Camacho, C M Pinsky, D W Braun, et al.
International Journal of Cancer|May 15, 1983
Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cellsP O Livingston, H Takeyama, M S Pollack, et al.
European Journal of Nuclear Medicine|January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2S Murthy, R M Sharkey, D M Goldenberg, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Annals of the New York Academy of Sciences|January 1, 1976
Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanomaC M Pinsky, Y Hirshaut, H J Wanebo, et al.
Cancer|October 1, 1976
Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's diseaseD C Case, J A Hansen, E Corrales, et al.
Blood|May 1, 1977
Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissionsD C Case, J A Hansen, E Corrales, et al.
Cancer Treatment Reports|November 1, 1978
Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary reportH J Wanebo, E Y Hilal, C M Pinsky, et al.
The New England Journal of Medicine|August 31, 1978
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancerH J Wanebo, B Rao, C M Pinsky, et al.
Annals of Surgery|December 6, 1997
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancerK Hughes, C M Pinsky, N J Petrelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study GroupF L Moffat, C M Pinsky, L Hammershaimb, et al.
Cancer|May 15, 1981
DNCB reactivity and prognosis in 419 patients with malignant melanomaE S Camacho, C M Pinsky, D W Braun, et al.
International Journal of Cancer|May 15, 1983
Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cellsP O Livingston, H Takeyama, M S Pollack, et al.
European Journal of Nuclear Medicine|January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2S Murthy, R M Sharkey, D M Goldenberg, et al.
Pageof 7